Collectively, these findings unveiled a previously unrecognised role for IGF2BP2 in regulating ferroptosis sensitivity and immune microenvironment remodelling in CRC, expanding our understanding of its multifaceted functions in cancer malignancy through both m6A‐dependent and independent mechanisms. The gene discussed is IGF2BP2; the disease is cancer.